CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform f... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 19, 2024 Category: Cardiology Authors: Oliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, Antonio Ceriello, Helena Elding Larsson, Beatriz Fern ández-Fernández, Thomas Forst, Juan-Pablo Frias, James R. Gavin III, Francesco Giorgino, Per-Henrik Groop, Hiddo J. L. Heerspink, Stephan Her Tags: Comment Source Type: research
Postpartum weight retention and the early evolution of cardiovascular risk over the first 5 years after pregnancy
The cumulative effect of postpartum weight retention from each pregnancy in a woman ’s life may contribute to her risk of ultimately developing type 2 diabetes and cardiovascular disease. However, there is limi... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Caroline K. Kramer, Chang Ye, Anthony J Hanley, Philip W Connelly, Mathew Sermer, Bernard Zinman and Ravi Retnakaran Tags: Research Source Type: research
Prevalence and prognostic significance of cardiac autonomic neuropathy in community-based people with type 2 diabetes: the Fremantle Diabetes Study Phase II
There is a paucity of contemporary data on the prevalence and prognostic significance of cardiac autonomic neuropathy (CAN) from community-based cohorts with type 2 diabetes assessed using gold standard method... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Timothy M. E. Davis, Eva Tan and Wendy A. Davis Tags: Research Source Type: research
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study
(Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk D éruaz-Luyet, Julie M. Paik and Elisabetta Patorno Tags: Correction Source Type: research
Effectiveness and safety of the combination of sodium –glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies
Randomized controlled trials and real-world studies suggest that combination therapy with sodium –glucose transport protein 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is ass... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Aftab Ahmad and Hani Sabbour Tags: Research Source Type: research
Triglyceride-glucose index: a novel evaluation tool for all-cause mortality in critically ill hemorrhagic stroke patients-a retrospective analysis of the MIMIC-IV database
Hemorrhagic stroke (HS), including non-traumatic intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH), constitutes a substantial proportion of cerebrovascular incidents, accounting for around 30% o... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 18, 2024 Category: Cardiology Authors: Yongwei Huang, Zongping Li and Xiaoshuang Yin Tags: Research Source Type: research
Hepatic insulin resistance and muscle insulin resistance are characterized by distinct postprandial plasma metabolite profiles: a cross-sectional study
Tissue-specific insulin resistance (IR) predominantly in muscle (muscle IR) or liver (liver IR) has previously been linked to distinct fasting metabolite profiles, but postprandial metabolite profiles have not... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 16, 2024 Category: Cardiology Authors: Anouk Gijbels, Bal ázs Erdős, Inez Trouwborst, Kelly M. Jardon, Michiel E. Adriaens, Gijs H. Goossens, Ellen E. Blaak, Edith J. M. Feskens and Lydia A. Afman Tags: Research Source Type: research
Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial
This study aimed to investigate whether shorter telomeres are associated with a ... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 16, 2024 Category: Cardiology Authors: Ana Ojeda-Rodriguez, Oriol A. Rangel-Zu ñiga, Antonio P. Arenas-de Larriva, Francisco M. Gutierrez-Mariscal, Jose D. Torres-Peña, Juan L. Romero-Cabrera, Alicia Podadera-Herreros, Helena García-Fernandez, Esther Porras-Pérez, Raul M. Luque, Stefanos N Tags: Research Source Type: research
Association between triglyceride-glucose index and intracranial/extracranial atherosclerotic stenosis: findings from a retrospective study
This study aimed to investigate the relati... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 14, 2024 Category: Cardiology Authors: Yu Xie, Kuan Cen, Bitang Dan, Li Zou, Lei Zhang, Renwei Zhang, Huagang Li, Qi Cai, Nadire Aiziretiaili, Zhenxing Liu and Yumin Liu Tags: Research Source Type: research
MCT4-dependent lactate transport: a novel mechanism for cardiac energy metabolism injury and inflammation in type 2 diabetes mellitus
Diabetic cardiomyopathy (DCM) is a major contributor to mortality in diabetic patients, characterized by a multifaceted pathogenesis and limited therapeutic options. While lactate, a byproduct of glycolysis, i... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 14, 2024 Category: Cardiology Authors: Xiu Mei Ma, Kang Geng, Peng Wang, Zongzhe Jiang, Betty Yuen-Kwan Law and Yong Xu Tags: Research Source Type: research
Sex differences in the relationship between serum total bilirubin and risk of incident metabolic syndrome in community-dwelling adults: Propensity score analysis using longitudinal cohort data over 16 years
Research on identifiable risks for metabolic syndrome (MetS) is ongoing, and growing evidence suggests that bilirubin is a potent antioxidant and cytoprotective agent against MetS. Ho... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 11, 2024 Category: Cardiology Authors: Ae Hee Kim, Da-Hye Son, Mid-Eum Moon, Soyoung Jeon, Hye Sun Lee and Yong-Jae Lee Tags: Research Source Type: research
The relative and combined ability of stress hyperglycemia ratio and N-terminal pro-B-type natriuretic peptide to predict all-cause mortality in diabetic patients with multivessel coronary artery disease
Stress hyperglycemia ratio (SHR) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are independently associated with increased mortality risk in diabetic patients with coronary artery disease (CAD). Ho... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 11, 2024 Category: Cardiology Authors: Le Wang, Chen Wang, Jia-chun Lang, Rong-di Xu, Hong ‑liang Cong, Jing‑xia Zhang, Yue‑cheng Hu, Ting-ting Li, Chun-wei Liu, Hua Yang and Wen‑yu Li Tags: Research Source Type: research
Underlying mechanisms and cardioprotective effects of SGLT2i and GLP-1Ra: insights from cardiovascular magnetic resonance
Originally designed as anti-hyperglycemic drugs, Glucagon-Like Peptide-1 receptor agonists (GLP-1Ra) and Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated protective cardiovascular effects, ... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 11, 2024 Category: Cardiology Authors: Angelica Cersosimo, Nadia Salerno, Jolanda Sabatino, Alessandra Scatteia, Giandomenico Bisaccia, Salvatore De Rosa, Santo Dellegrottaglie, Chiara Bucciarelli-Ducci, Daniele Torella and Isabella Leo Tags: Review Source Type: research
The worsening effect of paroxysmal atrial fibrillation on left ventricular function and deformation in type 2 diabetes mellitus patients: a 3.0 T cardiovascular magnetic resonance feature tracking study
Atrial fibrillation (AF) has been linked to an increased risk of cardiovascular death, overall mortality and heart failure in patients with type 2 diabetes mellitus (T2DM). The present study investigated the a... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 6, 2024 Category: Cardiology Authors: Xue-Ming Li, Wei-Feng Yan, Ke Shi, Rui Shi, Li Jiang, Yue Gao, Chen-Yan Min, Xiao-Jing Liu, Ying-Kun Guo and Zhi-Gang Yang Tags: Research Source Type: research
Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
Recent guidelines propose N-terminal pro-B-type natriuretic peptide (NT-proBNP) for recognition of asymptomatic left ventricular (LV) dysfunction (Stage B Heart Failure, SBHF) in type 2 diabetes mellitus (T2DM... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - March 6, 2024 Category: Cardiology Authors: Cheng Hwee Soh, Alex G. C. de S á, Elizabeth Potter, Amera Halabi, David B. Ascher and Thomas H. Marwick Tags: Research Source Type: research
